Daebong LS Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daebong LS Company Limited with three other
companies in this sector in KOREA (SOUTH) :
Kyung Nam Pharm Company Limited
sales of 70.95 billion Korean Won [US$59.81 million]
of which 37%
Korean Drug Co Ltd
(66.79 billion Korean Won [US$56.30 million]
of which 42%
was Neuromed,CNS), and
Choa Pharmaceutical Company Limited
(65.36 billion Korean Won [US$55.10 million]
of which 100%
was Medicine Sale).
During the second
quarter of 2021, sales at Daebong LS Company Limited totalled
22.08 billion Korean Won .
an increase of 7.1%
from the 20.63 billion Korean Won in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 40.71 billion Korean Won , which is
than through the first two quarters of 2020.
Daebong LS Company Limited reported sales of 76.25 billion Korean Won (US$64.28 million)
December of 2020.
increase of 9.7%
versus 2019, when the company's sales were 69.54 billion Korean Won .
Sales of Research saw an increase
17.4% in 2020, from
12.50 billion Korean Won to 14.68 billion Korean Won .
Not all segments of Daebong LS Company Limited experienced an increase in sales in 2020:
sales of Wholesale fell 11.5% to 364.52 million Korean Won .
(However, this segment's sales were only a very small portion of the company's overall sales).